3107530-08-2

DOTA-C1-FAP-2286 Chemical Structure
3107530-08-2

Chemical Structure

DOTA-C1-FAP-2286

  • CAS No.: 3107530-08-2
  • Formula:C73H109N15O26S5
  • Molecular Weight:1773.06

InChIKey: QSBCTGULVNSZJA-NCAZIDMLSA-N

SMILES: OC(CN(CCN1CC(O)=O)CCN(CCN(CC1)CC(O)=O)CC(N[C@@H](CS(=O)(O)=O)C(N[C@@H](CS(=O)(O)=O)C(NCCSCC2=CC(CSC[C@H](N3)C(O)=O)=CC(CSC[C@@H](C(N4[C@](CCC4)([H])C(N5[C@@](C(N[C@H](C(N[C@H](C(N[C@H](C3=O)CC6=CC=CC=C6)=O)CCC(N)=O)=O)[C@@H](C)O)=O)([H])CCC5)=O)=O)NC(CCCCC)=O)=C2)=O)=O)=O)=O

Biological Activity: DOTA-C1-FAP-2286 is a cysteic acid-modified fibroblast activation protein (FAP)-targeting radioligand. DOTA-C1-FAP-2286 binds competitively to FAP with an IC50 of 127.64 nM. DOTA-C1-FAP-2286 is targeted accumulation in FAP-expressing cells and exhibits accelerated renal clearance. DOTA-C1-FAP-2286 can be used as a PET/CT tracer in cancer[1].

Cat. No. Product Name Purity Description Pricing
HY-P11602
DOTA-C1-FAP-2286 DOTA-C1-FAP-2286 is a cysteic acid-modified fibroblast activation protein (FAP)-targeting radioligand. DOTA-C1-FAP-2286 binds competitively to FAP with an IC50 of 127.64 nM. DOTA-C1-FAP-2286 is targeted accumulation in FAP-expressing cells and exhibits accelerated renal clearance. DOTA-C1-FAP-2286 can be used as a PET/CT tracer in cancer.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide

References